The widely popular weight loss supplement Alli may be under fire soon, as the FDA has announce a review of Orlistat, marketed here in the US as the prescription drug Xenical and the OTC weight loss supplement Alli.
In a statement yesterday to healthcare professionals, the FDA made public an ongoing investigation into 32 reports of serious liver injury, including several cases if liver failure. Patients were taking orlistat, which is marketed under the trade name Xenical by Roche and Alli by GlaxoSmithKline.
Stay tuned for more information, but for now (08/25/09) the FDA is advising patients to continue using the product as directed.
If you have experienced jaundice (yellowing of the eyes or skin), darkening of urine, abdominal pain or other symptoms of liver damage, you are advised to consult with a medical professional to test the health of your liver. You should also contact the FDA’s Medwatch Adverse Event Reporting system if these symptoms or conditions occurred while or after taking Alli, Xenical, Orlistat or any other medication.